• Home
  • About Us
    • Mission
    • Leadership
    • Our Team
      • Core Faculty
      • OrgSupport
      • Researchers
    • Affiliated Members
    • Students
    • Visiting Scientists
    • Sabbatical Visitors
    • Former Members
  • Our Work
    • Amebiasis
    • African Sleeping Sickness
    • Chagas Disease
    • Filariasis
    • Hookworm
    • Leishmaniasis
    • Naegleriasis
    • Onchocerciasis
    • Schistosomiasis
  • Collaborations
    • Academic Collaborations
    • Non-Profit & Industry Collaborations
    • Success Stories
  • Press
    • Press Releases
    • Media
  • How to Help
    • Become a Partner
    • Donate
  •  
  • Home
  • Press
  • Media
  • Interview with schistosomiasis expert Conor Caffrey
  • Home
  • About Us
    • Mission
    • Leadership
    • Our Team
      • Core Faculty
      • OrgSupport
      • Researchers
    • Affiliated Members
    • Students
    • Visiting Scientists
    • Sabbatical Visitors
    • Former Members
  • Our Work
    • Amebiasis
    • African Sleeping Sickness
    • Chagas Disease
    • Filariasis
    • Hookworm
    • Leishmaniasis
    • Naegleriasis
    • Onchocerciasis
    • Schistosomiasis
  • Collaborations
    • Academic Collaborations
    • Non-Profit & Industry Collaborations
    • Success Stories
  • Press
    • Press Releases
    • Media
  • How to Help
    • Become a Partner
    • Donate
  •  

ConorCaffreyYouTube: Schistosomiasis expert, Conor Caffrey discusses drug discovery efforts towards addressing this life-threatening neglected disease and his perspectives on what the future holds for schistosomiasis treatment and prevention. Conor Caffrey recently guest edited a Future Medicinal Chemistry special focus issue on schistosomiasis. In recognition of the importance of open science in neglected disease drug discovery, the editorial team have made this issue free to access.

Designed by RocketTheme
Top